Cardiac sarcoidosis concomitant with large-vessel aortitis detected by 18F-fluorodeoxyglucose positron emission tomography

研究成果: ジャーナルへの寄稿記事

抄録

We herein report a case of concurrent cardiac sarcoidosis and large-vessel aortitis detected by18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and followed up during immunosuppressive therapy. After high-dose prednisolone administration (1 mg/kg), serial FDG-PET showed that almost all of the abnormal FDG uptake in the heart and extracardiac region, including the abdominal to bilateral iliac arteries, had been disappeared. During the tapering of prednisolone, additive methotrexate therapy was needed to treat the recurrence of cardiac sarcoidosis. FDG-PET is a useful tool for detecting cardiac sarcoidosis concomitant with large-vessel aortitis and monitoring the effectiveness of immunosuppressive therapy.

元の言語英語
ページ(範囲)1601-1604
ページ数4
ジャーナルInternal Medicine
57
発行部数11
DOI
出版物ステータス出版済み - 1 1 2018

Fingerprint

Aortitis
Fluorodeoxyglucose F18
Sarcoidosis
Positron-Emission Tomography
Immunosuppressive Agents
Prednisolone
Iliac Artery
Methotrexate
Therapeutics
Recurrence

All Science Journal Classification (ASJC) codes

  • Internal Medicine

これを引用

@article{49574b8bc0b543ee87ef0ad3a1d9c862,
title = "Cardiac sarcoidosis concomitant with large-vessel aortitis detected by 18F-fluorodeoxyglucose positron emission tomography",
abstract = "We herein report a case of concurrent cardiac sarcoidosis and large-vessel aortitis detected by18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and followed up during immunosuppressive therapy. After high-dose prednisolone administration (1 mg/kg), serial FDG-PET showed that almost all of the abnormal FDG uptake in the heart and extracardiac region, including the abdominal to bilateral iliac arteries, had been disappeared. During the tapering of prednisolone, additive methotrexate therapy was needed to treat the recurrence of cardiac sarcoidosis. FDG-PET is a useful tool for detecting cardiac sarcoidosis concomitant with large-vessel aortitis and monitoring the effectiveness of immunosuppressive therapy.",
author = "Yoshihiro Higuchi and yasutaka kimoto and Rika Tanoue and Tomotake Tokunou and Kenichiro Tomonari and Toyoki Maeda and Takahiko Horiuchi",
year = "2018",
month = "1",
day = "1",
doi = "10.2169/internalmedicine.9652-17",
language = "English",
volume = "57",
pages = "1601--1604",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "11",

}

TY - JOUR

T1 - Cardiac sarcoidosis concomitant with large-vessel aortitis detected by 18F-fluorodeoxyglucose positron emission tomography

AU - Higuchi, Yoshihiro

AU - kimoto, yasutaka

AU - Tanoue, Rika

AU - Tokunou, Tomotake

AU - Tomonari, Kenichiro

AU - Maeda, Toyoki

AU - Horiuchi, Takahiko

PY - 2018/1/1

Y1 - 2018/1/1

N2 - We herein report a case of concurrent cardiac sarcoidosis and large-vessel aortitis detected by18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and followed up during immunosuppressive therapy. After high-dose prednisolone administration (1 mg/kg), serial FDG-PET showed that almost all of the abnormal FDG uptake in the heart and extracardiac region, including the abdominal to bilateral iliac arteries, had been disappeared. During the tapering of prednisolone, additive methotrexate therapy was needed to treat the recurrence of cardiac sarcoidosis. FDG-PET is a useful tool for detecting cardiac sarcoidosis concomitant with large-vessel aortitis and monitoring the effectiveness of immunosuppressive therapy.

AB - We herein report a case of concurrent cardiac sarcoidosis and large-vessel aortitis detected by18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and followed up during immunosuppressive therapy. After high-dose prednisolone administration (1 mg/kg), serial FDG-PET showed that almost all of the abnormal FDG uptake in the heart and extracardiac region, including the abdominal to bilateral iliac arteries, had been disappeared. During the tapering of prednisolone, additive methotrexate therapy was needed to treat the recurrence of cardiac sarcoidosis. FDG-PET is a useful tool for detecting cardiac sarcoidosis concomitant with large-vessel aortitis and monitoring the effectiveness of immunosuppressive therapy.

UR - http://www.scopus.com/inward/record.url?scp=85047866363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047866363&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.9652-17

DO - 10.2169/internalmedicine.9652-17

M3 - Article

VL - 57

SP - 1601

EP - 1604

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 11

ER -